NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.7574
-0.0016 (-0.21%)
At close: Jun 26, 2026, 4:00 PM EDT
0.7590
+0.0016 (0.21%)
After-hours: Jun 26, 2026, 6:47 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $26.77 million as of June 26, 2026. Its market cap has decreased by -55.18% in one year.
Market Cap
26.77M
Enterprise Value
26.78M
1-Year Change
-55.18%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $26.77M, a decrease of -58.56%. That is a compound annual growth rate of -17.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 26.77M | 17.23% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tevogen Bio Holdings | 29.31M |
| Kyntra Bio | 29.31M |
| Dyadic International | 29.19M |
| Plus Therapeutics | 28.91M |
| Vistagen Therapeutics | 28.80M |
| Barinthus Biotherapeutics | 28.59M |
| Serina Therapeutics | 27.15M |
| BriaCell Therapeutics | 26.67M |